The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund the fourth annual cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop. In partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), the program seeks to broaden the foundational knowledge of FTD to spur diagnostic and therapeutic advancements. The SPARC online grant portal is now accepting applications for two-year projects to conduct basic or early-stage translational research on this topic. 

Description and Background

The Kissick Family Foundation FTD Grant Program intends to award up to five two-year research grants led by doctoral-level investigators at qualifying research-based institutions worldwide. Projects will be eligible for up to US$500,000 in funding over two years, inclusive of indirect costs. The Grant Program will support fundamental science and early-stage translational research in sporadic FTD. Early-stage translational research refers to preclinical studies that bridge basic discoveries with future clinical applications. The Grant Program requires applicants to be independent investigators and encourages submissions from early-career investigators, who are a priority for this funded cohort. More details on the scientific scope and eligibility criteria are found below.

FTD is a family of neurodegenerative conditions that cause changes in behavior, mood, executive function, language, memory, and motor function. Based on brain pathology, FTD could account for as many as 10–20 percent of all dementia cases. The disease is underdiagnosed, and a true global prevalence estimate is hindered by a general lack of awareness and the complex nature of its detection. The hallmark biological trait of FTD is a progressive deterioration of the brain’s frontal and temporal lobes, but specific biomarkers or treatments for FTD have not been developed.

Research into FTD linked to the known autosomal dominant genes GRN, MAPT, and C9orf72 drives most of the current scientific development. Yet only about 25–30 percent of patients have identified genetic causes, pointing to the need for targeted research to understand sporadic FTD that occurs outside of the autosomal dominant forms. Therefore, this request for proposals (RFP) solicits projects that address the fundamental etiologies and mechanisms for sporadic FTD. For the purposes of this RFP, sporadic FTD is defined as FTD that develops without an identified known causal gene mutation.

Building on the momentum of its first three grant cycles, the Foundation will continue to champion research that is bold, rigorous, collaborative, and catalytic. The Kissick Family Foundation Dementia Portfolio—grounded in a deep commitment to scientific excellence and transformative impact—seeks to generate novel scientific findings, strengthen the global research ecosystem, and accelerate progress toward deeper understanding, earlier diagnosis, and more effective treatments for individuals living with FTD and related neurodegenerative diseases.

Scientific Scope

The Kissick Family Foundation FTD Grant Program aims to accelerate basic discoveries, introduce novel research approaches, and, ultimately, improve patient outcomes for people living with FTD. A broad range of topics is responsive to this call. For example, proposals may target the disease’s basic biology, propose computational and data-driven approaches that can generate new insights, develop and validate biomarkers that can be used to diagnose and track disease progression more effectively, or preclinically assess novel therapeutic targets.

All responsive applications must examine factors that are not exclusive to the autosomal dominant genetic pathways and instead must have clear relevance to sporadic FTD. Emerging scientific evidence suggests that genetically autosomal dominant and sporadic FTD share common biological processes, such as pathological protein aggregation, impaired cellular waste management, and neuroinflammation; further study of these and other cellular mechanisms is in scope for this program and may accelerate discovery in all forms of FTD research. Additionally, projects may include the use of GRN, MAPT, or C9orf72 models with justification of how findings will inform sporadic FTD beyond known genetic causes. We encourage applications targeting any proteinopathies or molecular subtypes of sporadic FTD and recognize that insights from rarer proteinopathies may also advance understanding of broader FTD mechanisms. Finally, computational approaches using datasets that include other dementias or neurodegenerative diseases are welcome, but applications should specifically indicate their relevance to sporadic FTD.

We will prioritize proposals that use intentionally creative approaches and interrogate emerging hypotheses to advance the fundamental understanding of sporadic FTD. Informed by the current state of the field, example topics include but are not restricted to:

• Interactions between co-pathologies and their influence on disease progression
• Computational approaches, including AI and machine learning, to uncover hidden patterns in complex datasets, enhance biomarker discovery, and enable predictive modeling of FTD
• Clinical biomarkers—including fluid (e.g., CSF, blood), imaging-based, proteomic, and genetic markers—to support early diagnosis, disease staging, patient stratification, and progression monitoring
• Synaptic dysfunction and alterations in neural circuitry as early contributors to FTD pathogenesis
• Innovative approaches to identify novel genetic risk factors and/or disease pathways implicated in sporadic FTD
• Proteinopathies and molecular subtypes that define distinct forms of FTD and inform targeted therapeutic development
• Novel neuroimaging methods and modalities that enable tracking of FTD-related changes in living tissue
• Microglia and other non-neuronal cells implicated in FTD pathogenesis
• Environmental and exposome-related factors that influence disease risk, onset, or progression
• Development and application of innovative experimental models, including models that more faithfully recapitulate sporadic FTD biology

This list of topics should be considered non-exhaustive and illustrative; we welcome any novel, insightful, and high-quality research that advances our understanding of sporadic FTD. 

We also encourage applicants from outside traditional FTD research domains or disciplinary origins, including investigators working with emerging technologies, novel tools, or methodologies that could be applied to FTD, even if not previously used in this context. This includes, but is not limited to, researchers in computational biology, imaging, AI/machine learning, immunology, structural biology, systems neuroscience, and biophysics. Regardless of the applicant’s discipline, representation on the investigative team should include sufficient knowledge of FTD biology.

Finally, the Kissick Family Foundation is committed to cultivating a robust and diverse FTD research ecosystem and therefore strongly encourages early-career and newly independent investigators to apply. Building up the next generation of FTD scientists is a core priority for the Foundation, and early-career applicants are especially encouraged to respond to this call.

Eligibility Criteria

1. Each applicant organization must be a nonprofit academic or research institution, including domestic and non-US nonprofit organizations and domestic and non-US public/private academic universities or institutions of higher learning (including colleges, universities, medical schools, and other related academic research institutions); certain qualified governmental agencies with active biomedical research programs may also apply.  
2. All proposed research projects must be led by a designated principal investigator (PI) who holds a PhD, MD, or related research doctoral degree. 
3. The PI must be an independent investigator as defined by the host institution.  
4. Early-career investigators are encouraged to apply. Early-career investigators are those who have either not yet received substantial independent federal funding for their independent research programs or are within five years of the start date of their first independent faculty or research-group-leader appointment as of the letter of intent (LOI) deadline (with reasonable extensions for documented parental, medical, caregiver, or equivalent leave). This status is collected to help inform portfolio representation and does not affect scientific scoring.
5. Multidisciplinary investigator collaborations are encouraged to apply. Collaborators should be identified as co-investigators and provide the materials described in the sections below. Proposals with co-investigators must identify a single corresponding PI and submitting institution. 
6. Institutions may submit multiple proposals, but a unique PI must lead each proposal.
7. Applicants may not be currently funded by the Kissick Family Foundation either as PIs or co-investigators on any FTD grants. Junior investigators who are embedded in laboratories already receiving Kissick Family Foundation FTD funding (e.g., postdoctoral researchers or staff scientists working under funded PIs) are not eligible as described in criterion 3.

Application Requirements

All completed LOIs and proposals should be submitted through the SPARC online grant portal at https://milken.smapply.io/prog/ftd_grant_program/. Below is a list of required components for an application to be considered complete.

Applications should be single-spaced and formatted using a legible font (minimum 11-point size) with one-inch margins, except where provided templates apply. The SPARC team encourages formatting consistency to support ease of review, and as such, applications that do not follow the requirements may not be considered.

Letter of Intent (maximum 750 words)

All applicants must first submit an LOI, which allows the scientific review team to ensure applicant eligibility, determine whether the proposed research fits within the funding program’s scope, and invite a subset of the most promising applications to submit full proposals. Proposed work must be focused on basic or early-stage translational research in FTD. Clinical trials or studies that are exclusively focused on familial FTD will not be considered. 

The LOI should include the following information (750-word maximum):

• Project title 
• PI name and institution
• Co-investigator name(s) and institution(s), if applicable
• Project aims 
• The scientific priority area—described above, within the Scientific Scope—or other important gap within sporadic FTD research that the project will address 
• A succinct description of the proposed research approach
• How this proposal integrates elements of innovation within the FTD field, such as by testing a novel hypothesis, integrating new methods or technologies, or bringing new ideas and perspectives to FTD
• How the proposed research would be significant in furthering our understanding of how or why sporadic FTD develops, its progression, and/or how it can be better diagnosed
• How this idea or proposed line of research would specifically benefit from the Kissick Family Foundation funding opportunity
• One reasonably sized figure (<½ page) is acceptable and will not count against the word limit.
• Via a separate form within the application portal, the applicant organization’s legal name; PI name, degree, position, whether you are an early-career investigator, and contact information; co-investigator(s) name, degree, and position; and the organization’s tax ID (for US) or registered charity number.  

LOIs are due Wednesday, November 4, 2026, through the SPARC online grant portal, which can be accessed via this link: https://milken.smapply.io/prog/ftd_grant_program/.

Eligible applicants proposing a project within the scope of this funding program should submit scientifically rigorous, innovative research studies with significant potential to further our understanding of sporadic FTD. Should the Kissick Family Foundation, in its sole discretion, find that a project described in an LOI meets these criteria and is among the top applications, the applicant will be invited to submit a full proposal.  

Full Proposal Requirements

Scientific Proposal (maximum six pages)

Applicants invited to submit a full application must include a formal proposal outlining the intended project. Proposals are due Tuesday, February 9, 2027.

Proposals should be no more than six pages in length and must include the following materials organized in the following order. Preliminary data are not mandatory.

• Project Summary: One page maximum, including the following information:
  • Project title
  • Abstract
  • Aims and milestones: summary of the project’s plan, what it aims to accomplish, and the major milestones it will complete in an estimated time frame 
  • Name, degrees, positions, and institutions of the PI and, if applicable, co-investigators
• Scientific Approach: Five pages maximum, inclusive of figures and references in the applicant’s preferred format, including the following sections:
  • Project Goal and Significance: Statement of what the project plans to accomplish and why the proposed research is important, with a high potential for impact on the FTD field and sporadic FTD.
  • Background: Description of the scientific rationale and foundational knowledge that underlie the proposed research; preliminary data are not mandatory.
  • Methods: Description of the research methods the PI intends to use in pursuit of the aims. Please provide enough detail to explain how the proposed experiments will rigorously interrogate the central scientific question and, if applicable, how the approach could be scaled to expanded studies in the future.
  • Timeline: Statement of how the PI plans to accomplish the project goal and scientific aims within a two-year grant term.

Protocol Synopsis and Data-Sharing Plan (maximum one page)

Proposals must include a succinct, technical protocol synopsis that details the methods, processes, and protocols being used in the project. Include an acquisition plan for obtaining necessary research resources (e.g., tissue samples, equipment, or model organisms) and additional timelines, if applicable. 

Applicants must also describe their commitment to openly sharing project results and other collateral, such as data (de-identified, where applicable), reagents, protocols, and other research tools developed under Kissick Family Foundation funding. PIs are expected to describe their plan for data sharing and how research products are disseminated to other institutions and researchers for noncommercial use to advance the fundamental understanding of FTD and maximize scientific impact. This page will be included in the appendix of all grant agreements.

• Applicants should identify the specific repository to which they intend to upload and share project protocols, datasets, and study results.
• Applicants are expected to upload study results to preprint servers.
• Applicants are strongly encouraged to publish any manuscripts resulting from funded research in an open-access venue and are permitted to include article processing charges for open-access publications in their proposed budget.
• Applicants should describe policies and procedures for ensuring that key personnel and other applicable employees and contractors comply with and adhere to the data-sharing plan.
• Fees and costs associated with data management and sharing are allowable expenditures.

Research Team (maximum one page)

Applicants must outline the research group’s ability to address the proposed scientific question and support the research. This statement should identify key personnel through a full roster of project team members in addition to the PI and co-investigator(s).

Detailed Budget (template provided)

Applicants must provide a detailed budget using the template provided. The detailed budget in USD should be accompanied by a narrative summary and budget justification, including how the PI and any co-investigators, if applicable, intend to spend their time on the project. Projects can be budgeted for two years and up to US$500,000 (about US$250,000 per year), inclusive of up to 15 percent indirect costs. If more than one institution will be involved in the project, one should be proposed as the applicant organization and the other included as a sub-grantee, and the maximum allowable indirect rate across all institutions will remain 15 percent of the total award budget. Acceptable expenditures for direct costs include:

• salary for the PI, co-investigators (if applicable), graduate students, postdocs, staff scientists, and other personnel;
  • fringe benefits for the PI, co-investigators (if applicable), graduate students, postdocs, staff scientists, and other personnel;
    • equipment, supplies, and software;
    • computing and data storage costs, including support for data management and sharing;
    • any fees required to access or use human tissue, samples, datasets, or animal models;
    • project-related travel, such as to conferences, to share research results or between institutions to facilitate a collaborative project; 
    • publication costs, including article processing charges for open-access publications; and
    • up to 15 percent of funded institutions’ indirect expenses. It is not necessary to provide specific details regarding indirect cost expenditure. 

Grants selected for funding will be made payable to the applicant’s organization. Under no circumstances will funding be paid to, or earmarked for, any individual. International applicants should note that grants will be made in USD, and the Kissick Family Foundation is not responsible for changes in conversion rates. Payments will be made annually.

PI Biosketches 

A biosketch of the PI and co-investigators (if applicable), using the National Institutes of Health (NIH) template (Common Form), is required per PI. If the PI or co-investigators do not have a biosketch in an NIH template, a CV is sufficient.

Institutional Letter of Commitment

Each full application must include an institutional letter of commitment stating that the applicant institution will be able to support the research led by the PI and administer the grant according to a written grant agreement to be entered into between the selected organization and the Kissick Family Foundation. Note that this is not a requirement at the LOI stage. The letter should be signed by an authorized organizational representative (e.g., department chair or dean of sponsored research). Collaborative applications from multiple institutions can either submit separate letters of commitment from each institution or have one letter signed by all relevant authorized institutional representatives from each institution. There is no required template for this letter.

• Additional documentation within the online form will include a completed electronic signature confirming that the grant proposal contains information that is true, complete, and accurate and that false or fraudulent statements may subject the institution to criminal, civil, or administrative penalties.
• Upon request, an applicant institution may be required to submit additional information to document its nonprofit status.
• Non-US-based governmental organizations must also provide:
  • A list of voting board members and officers, as well as the name of the organization’s highest-ranking member (e.g., CEO).
    • Additional organization governing documents and other documentation via a secondary questionnaire, following your proposal submission. The Kissick Family Foundation will make this request during the proposal review. For more information, please visit https://www.ngosource.org/how-an-ed-works.
  • US-based governmental organizations (excluding academic/research institutions that are public charities) must provide:
    • A full copy of the enabling statute that authorized the organization’s creation.
    • A copy of the organization’s governing documents (such as articles of organization or constitution, and bylaws), if applicable. 
    • Any correspondence from the Internal Revenue Service confirming the organization’s tax status, if applicable.

Key Dates and Timeline

1. Tuesday, October 13, 2026: An informal information session for interested applicants will be held at 11 a.m. US Eastern Time (8 a.m. Pacific, 5 p.m. Central European). Attendees must register using this Zoom registration link.
2. Wednesday, November 4, 2026: Letter of Intent is due. Submit via the SPARC online grant portal by 11:59 p.m. US Eastern Time.
3. Full proposals are invited following LOI review in mid-December 2026.
4. Tuesday, February 9, 2027: Applicants should submit their full proposals via the online grant portal by 11:59  p.m. US Eastern Time.
5. Awardees notified as early as June 2027.

Selection Process

Selection Criteria

Applications displaying strength across the following domains will be more likely to be selected for funding by the Kissick Family Foundation.

• Scientific and technical merit: The quality of the scientific rationale and the use of resources, equipment, and experimental designs to evaluate the central scientific question rigorously or test the stated hypothesis/hypotheses. Experimental design is highly rigorous, and the study is appropriately statistically powered to produce meaningful findings even in the absence of supportive or positive results.
• Significance and potential impact: The success of this proposed research would be significant in furthering our fundamental understanding of sporadic FTD, demonstrating potential to lead to breakthrough discoveries for the disease, and achieving near-term scientific impact.
• Innovation: A proposal’s ability to bring new ideas, knowledge, methods, approaches, or perspectives to the FTD field and generate new avenues to understand, diagnose, treat, manage, prevent, or cure FTD. Projects introduce new technologies, methods, hypotheses, perspectives, or investigators to the field.
• Team capabilities and competencies: The research group’s ability to address the research question and support the research.
• Cost realism: A realistic budget that adequately supports personnel, equipment, overhead, open-access publishing costs, and other needs to carry out the project successfully.

Review Process

Funding decisions will be made after a multistep review process comprising the following:

• Eligibility and scientific scope review: As described above, LOIs will first be reviewed by the scientific review team to ensure applicant eligibility and determine whether the proposal fits within the funding program’s scope.
• Peer review: Full applications will be peer-reviewed by an external panel of expert reviewers utilizing the selection criteria described above. Applications will be ranked according to peer review, and a select number of highly prioritized applications will move forward to the next round of evaluation.
• Scientific leadership review: The FTD Grant Program’s scientific leadership—including the Scientific Advisory Board—will evaluate the highly prioritized peer-reviewed applications and overlay program strategy to achieve an overall grant portfolio that meets the fund’s goals.
• Kissick Family Foundation determination: The scientific leadership of the FTD Grant Program will provide a final prioritized list of funding recommendations to the Kissick Family Foundation for consideration. The Kissick Family Foundation will make final funding decisions, and applications will be funded subject to a written agreement, as further discussed below.   

Progress Reporting and Evaluation

Funded investigators will be expected to share updates on project highlights, progress, and challenges.

• At 12 and 18 months after receiving funding, each PI will provide short, written updates describing major project progress based on milestones identified when the proposal was submitted and any challenges they have faced along the way. Depending on the substance of these updates, PIs may be asked to engage in brief conversations with the program’s scientific leadership.
• At the end of the grant term, PIs will submit a full, written narrative and financial report for the overall project. 
• Funded investigators are expected to participate in annual funded investigators’ meetings to present and discuss their research plans, progress, and preliminary and/or unpublished results arising from research supported by the Kissick Family Foundation. These meetings are an important component of the program and are intended to foster collaboration, shared learning, and exchange of insights across the community of funded investigators. Expenses associated with participation in the meeting will be funded separately.

Grant Terms

Each funded research institution and PI will be required to cosign and agree in writing to the Kissick Family Foundation’s grant terms within 30 days from receipt of notice of the award and prior to funds being released. The grant terms include, but are not limited to, the following items.

Any substantial changes to the project, including activities, budget, protocols, or grant period, require written approval from the Kissick Family Foundation before proceeding with such activities or spending or committing any remaining funds from the grant.

Use of Funds

• The applicant organization must be able to receive awarded funds and allocate them toward the funded FTD research project.
• Institutional review board or the local equivalent (for human studies) or institutional animal care and use committee or the local equivalent (for animal studies) approval will be required before initial payments are made.
• If an applicant organization proposes to supplement any funds provided by the Kissick Family Foundation with funds provided by a third party, the organization must first provide notice to the Kissick Family Foundation and must ensure that the funding terms that attach to any such third-party funds do not preclude sharing of data or publication of project results as contemplated in this RFP.
• Teams may request no-cost extensions no less than 30 days before the end of the grant term. 

Intellectual Property and Sharing Data and Results

Each funded organization shall own the rights to all intellectual property developed by or on behalf of that organization under the Kissick Family Foundation funding, in accordance with such organization’s applicable intellectual property policies. The Kissick Family Foundation shall have the right to use and practice all such intellectual property for internal, noncommercial research purposes. The Kissick Family Foundation would also have the right to publicly disclose research results in press releases, announcements, and otherwise (subject to the funded organization’s advance approval if any such public disclosure will occur prior to publication of the applicable results or the filing for intellectual property).

Each funded organization must agree to share project results and other collateral, such as data (de-identified, where applicable), reagents, protocols, and other research tools developed under the Kissick Family Foundation funding with other researchers for noncommercial use to advance the understanding of FTD and to maximize scientific and patient impact.

It is a condition of any funding provided by the Kissick Family Foundation that the investigator seeks to publicly release the results of the funded project, such as on a preprint server, within 12 months after completion of the project. Furthermore, funded investigators are strongly encouraged to publish the results of the funded project in an open-access, peer-reviewed journal within 18 months after the completion of the project. Each publication would acknowledge the Kissick Family Foundation’s role in supporting the project. If the investigator does not publish the results within such a time frame, the Kissick Family Foundation shall have the right to make such results public. Specific financial support for such publications is an allowable expense in the project budget. Funded investigators must inform the Kissick Family Foundation of any publication supported by their funds within 30 days of publication.

Funding Awarded at the Kissick Family Foundation’s Discretion

Responding to this RFP, submitting an LOI, and/or submitting a full proposal do not entitle any individual or institution to receive funding from the Kissick Family Foundation. Funding, if any, would be provided at the Kissick Family Foundation’s sole discretion pursuant to the terms of a written grant agreement executed by the Milken Institute on behalf of the Kissick Family Foundation with the selected awardee institution and acknowledged by the PI.

Contact Information

For all inquiries about the online process, necessary documentation, research priorities, or scientific requirements, please contact [email protected].

An automated email confirmation is generated upon submission of the application. If you do not receive confirmation within 24 hours of submitting your application, please check your spam filters and then contact [email protected].